本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Janux Therapeutics, Inc.

23.01
-1.2900-5.31%
盘后23.010.00000.00%19:55 EDT
成交量:54.14万
成交额:1,266.49万
市值:13.83亿
市盈率:-12.81
高:24.35
开:24.30
低:22.90
收:24.30
52周最高:71.71
52周最低:21.97
股本:6,009.39万
流通股本:4,496.69万
量比:0.66
换手率:1.20%
股息:- -
股息率:- -
每股收益(TTM):-1.7966
每股收益(LYR):-1.2836
净资产收益率:-12.82%
总资产收益率:-10.51%
市净率:1.40
市盈率(LYR):-17.93

数据加载中...

2025/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/07

重要事件披露

Form 8-K - Current report
2025/06/13

重要事件披露

Form 8-K - Current report
2025/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/08

重要事件披露

Form 8-K - Current report
2025/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

重要事件披露

Form 8-K - Current report
2025/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/05

重要事件披露

Form 8-K - Current report
2024/12/02

重要事件披露

Form 8-K - Current report
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]